CLSA Initiates Coverage On Charles River with Underperform Rating, Announces Price Target of $167
Portfolio Pulse from Benzinga Newsdesk
CLSA has initiated coverage on Charles River Laboratories (NYSE:CRL) with an Underperform rating and set a price target of $167.
October 23, 2024 | 10:46 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CLSA has initiated coverage on Charles River Laboratories with an Underperform rating and a price target of $167, suggesting potential downside.
The Underperform rating and price target of $167 from CLSA suggest that the stock may face downward pressure as investors react to the negative outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100